General
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Carbamoyl-phosphate synthetase 1 (CPS1) is a mitochondrial enzyme encoded by the CPS1 gene in humans. It catalyzes the first and rate-limiting step of the urea cycle, converting ammonia and bicarbonate into carbamoyl phosphate. This reaction is crucial for detoxifying excess nitrogen by converting ammonia into urea, which is then excreted by the kidneys (Pierson and Brien, 1980; Rubio and Grisolia, 1981; Pekkala et al, 2009; Diez-Fernandez et al, 2013; reviewed in Martinez et al, 2010; Nitzahn and Lipshutz, 2020). CPS1 is predominantly expressed in the liver and plays a vital role in nitrogen metabolism. It is also present in the enterocytes of the small intestine, where it contributes to pyrimidine biosynthesis and the production of circulating citrulline and arginine (Ryall et al, 1985). CPS1 activity is regulated by various factors, including the availability of its allosteric activator, N-acetyl-L-glutamate (NAG), and hormonal signals such as glucagon and glucocorticoids (Rubio et al, 1983; Pekkala et al, 2009; de Cima et al, 2015). Deficiencies in CPS1 can lead to carbamoyl phosphate synthetase I deficiency (CPS1D), a rare autosomal recessive disorder characterized by hyperammonemia (Freeman et al, 1970; reviewed in Martinez et al, 2010; Zhang et al, 2023). This condition results from mutations in the CPS1 gene, leading to a dysfunctional enzyme that cannot effectively process ammonia. Symptoms of CPS1D include poor feeding, vomiting, lethargy, and, if untreated, can progress to seizures, coma, and death (reviewed in Martinez et al, 2010; Zhang et al, 2023).